Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IM Cannabis (IMCC) Receivables (2019 - 2026)

IM Cannabis has reported Receivables over the past 8 years, most recently at $5.2 million for Q1 2026.

  • For Q1 2026, Receivables changed N/A year-over-year to $5.2 million; the TTM value through Mar 2026 reached $5.2 million, changed N/A, while the annual FY2025 figure was $7.9 million, 22.86% down from the prior year.
  • Receivables was $5.2 million for Q1 2026 at IM Cannabis, down from $7.9 million in the prior quarter.
  • Across five years, Receivables topped out at $10.1 million in Q4 2024 and bottomed at $979497.6 in Q2 2024.
  • The 5-year median for Receivables is $6.4 million (2022), against an average of $6.2 million.
  • Year-over-year, Receivables plummeted 55.44% in 2022 and then surged 59.69% in 2024.
  • Over 5 years, Receivables stood at $6.5 million in 2022, then decreased by 3.52% to $6.3 million in 2023, then surged by 59.69% to $10.1 million in 2024, then decreased by 21.29% to $7.9 million in 2025, then tumbled by 34.12% to $5.2 million in 2026.
  • The last three reported values for Receivables were $5.2 million (Q1 2026), $7.9 million (Q4 2025), and $10.1 million (Q4 2024) per Business Quant data.